Avecho Biotechnology Limited (AVEFF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -3.17 Million | -1.66 Million | -3.09 Million | -1.42 Million | 1.18 Million | -2.14 Million |
| Net Income | -3.43 Million | -2.34 Million | -3.41 Million | -2.63 Million | 849.95 Thousand | -3.99 Million |
| Depreciation & Amortization | 178.69 Thousand | 230.35 Thousand | 428.59 Thousand | 536.62 Thousand | 683.45 Thousand | 725.63 Thousand |
| Deferred income taxes | -102.73 Thousand | -675.23 Thousand | -557.92 Thousand | -530.32 Thousand | -18.68 Thousand | - |
| Stock-based compensation | 102.73 Thousand | 203.26 Thousand | 557.92 Thousand | 530.32 Thousand | 18.68 Thousand | 47.84 Thousand |
| Change in working capital | -390.05 Thousand | 241.61 Thousand | -690.93 Thousand | 324.78 Thousand | -489.41 Thousand | 898.55 Thousand |
| Other non-cash items | 467.96 Thousand | 677.18 Thousand | 579.78 Thousand | 350.27 Thousand | 144.81 Thousand | 430.28 Thousand |
| Investing Cash Flow | - | -53.12 Thousand | -202.29 Thousand | -4357.00 | 11.05 Thousand | 41.84 Thousand |
| Investments in PPE | - | -53.12 Thousand | -202.82 Thousand | -5150.00 | - | -424.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | 531.00 | 793.00 | 11.05 Thousand | 42.27 Thousand |
| Financing Cash Flow | 7.21 Million | -78.22 Thousand | 4.69 Million | -82.5 Thousand | -89.43 Thousand | 1.35 Million |
| Debt repayment | -70.92 Thousand | -80.21 Thousand | -72.31 Thousand | -82.5 Thousand | -89.43 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -716.52 Thousand | - | -294.2 Thousand | - | - | -13.49 Thousand |
| Common Stock Issuance | 7.28 Million | 1989.00 | 5.06 Million | - | - | 1.37 Million |
| Other Financing Activities | -70.92 Thousand | -80.21 Thousand | -72.31 Thousand | -82.5 Thousand | -89.43 Thousand | 1.35 Million |
| Accounts receivables | -353.56 Thousand | 404.77 Thousand | -671.64 Thousand | 276.31 Thousand | -78.4 Thousand | 1.71 Million |
| Accounts payables | -94.46 Thousand | 25.83 Thousand | 33.82 Thousand | 53.13 Thousand | -390.37 Thousand | -666.87 Thousand |
| Inventory | -60.73 Thousand | -205.24 Thousand | -96.72 Thousand | 48.75 Thousand | -48.91 Thousand | 191.79 Thousand |
| Other working capital | 118.71 Thousand | 42.09 Thousand | 43.61 Thousand | -53.42 Thousand | 28.27 Thousand | -344.05 Thousand |
| Cash at beginning of period | 1.46 Million | 3.26 Million | 1.87 Million | 3.21 Million | 2.11 Million | 2.89 Million |
| Cash at end of period | 5.5 Million | 1.46 Million | 3.26 Million | 1.87 Million | 3.21 Million | 2.11 Million |
| Capital Expenditure | - | -53.12 Thousand | -202.82 Thousand | -5150.00 | - | -424.00 |
| Effect of forex changes on cash | - | - | -531.00 | 173.05 Thousand | -11.05 Thousand | - |
| Net cash flow / Change in cash | 4.03 Million | -1.79 Million | 1.39 Million | -1.33 Million | 1.09 Million | -787.42 Thousand |
| Free Cash Flow | -3.17 Million | -1.71 Million | -3.3 Million | -1.42 Million | 1.18 Million | -2.14 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.08 Million | -1.08 Million | -3.43 Million | -1.3 Million | -654.52 Thousand | -2.12 Million |
| Depreciation & Amortization | 37.35 Thousand | 37.35 Thousand | 178.69 Thousand | 74.35 Thousand | 37.17 Thousand | 104.33 Thousand |
| Deferred income taxes | - | - | -102.73 Thousand | 57.88 Thousand | - | - |
| Stock-based compensation | 7009.00 | 7009.00 | 102.73 Thousand | 20.38 Thousand | 20.38 Thousand | 30.97 Thousand |
| Change in working capital | - | - | -390.05 Thousand | -226.98 Thousand | -226.98 Thousand | - |
| Other non-cash items | 729.13 Thousand | 729.13 Thousand | 467.96 Thousand | -1.39 Million | -565.83 Thousand | 1.83 Million |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -18.87 Thousand | -18.87 Thousand | 7.21 Million | 5.41 Million | 2.7 Million | 1.8 Million |
| Debt repayment | - | - | -70.92 Thousand | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -716.52 Thousand | - | - | - |
| Common Stock Issuance | - | - | 7.28 Million | 5.45 Million | - | 1.83 Million |
| Other Financing Activities | -18.87 Thousand | -18.87 Thousand | -70.92 Thousand | 2.7 Million | 2.7 Million | 900.26 Thousand |
| Accounts receivables | - | - | -353.56 Thousand | -176.78 Thousand | -176.78 Thousand | - |
| Accounts payables | - | - | -94.46 Thousand | - | - | - |
| Inventory | - | - | -60.73 Thousand | -30.36 Thousand | -30.36 Thousand | - |
| Other working capital | - | - | 118.71 Thousand | -19.83 Thousand | -19.83 Thousand | - |
| Cash at beginning of period | 5.5 Million | - | 1.46 Million | 2.86 Million | - | 1.46 Million |
| Cash at end of period | 4.83 Million | -332.99 Thousand | 5.5 Million | 5.5 Million | 1.31 Million | 2.86 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -665.98 Thousand | -332.99 Thousand | 4.03 Million | 2.63 Million | 1.31 Million | 1.4 Million |
| Free Cash Flow | -314.12 Thousand | -314.12 Thousand | -3.17 Million | -2.77 Million | -1.38 Million | -400.39 Thousand |
UV-R
1979
ASAZF
4533
2322
ENTO